FDA OKs Lilly-Amylin Drug for Type 2 Diabetes (Reuters)


Reuters - U.S. regulators have approved a
diabetes drug derived from lizard saliva for patients who have
not responded to other treatments, the drug's developers, Eli
Lilly and Co. and Amylin Pharmaceuticals Inc., said on Friday.

Read more...